158 related articles for article (PubMed ID: 33089140)
1. Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series.
Marumoto H; Tsuboi N; Kawamura T; Yokoo T
Kidney Med; 2020; 2(5):620-628. PubMed ID: 33089140
[TBL] [Abstract][Full Text] [Related]
2. Non-immunosuppressive treatment for IgA nephropathy.
Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
[TBL] [Abstract][Full Text] [Related]
3. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy.
Nagai M; Kobayashi N; Izumi N; Ohbayashi T; Hotta O; Hamano T
J Nephrol; 2022 Mar; 35(2):441-449. PubMed ID: 34014510
[TBL] [Abstract][Full Text] [Related]
5. Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatment.
Kondo N; Moriyama T; Tachikawa M; Tomita E; Hattori A; Yamamura Y; Nonaka M
Auris Nasus Larynx; 2019 Oct; 46(5):764-771. PubMed ID: 30665673
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of tonsillectomy in renal transplant patients with recurrent IgA nephropathy].
Zhu L; Feng H; Jia JD; Peng S; Li YQ; Shao JF; He XF; Guan Y; Guo H; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(3):176-180. PubMed ID: 29374910
[No Abstract] [Full Text] [Related]
7. Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study.
Hoshino J; Fujii T; Usui J; Fujii T; Ohashi K; Takaichi K; Suzuki S; Ubara Y; Yamagata K
Clin Exp Nephrol; 2016 Aug; 20(4):618-627. PubMed ID: 26577676
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial.
Yang D; He L; Peng X; Liu H; Peng Y; Yuan S; Liu Y; Chen X; Liu F; Liu C
Ren Fail; 2016; 38(2):242-8. PubMed ID: 26727697
[TBL] [Abstract][Full Text] [Related]
9. Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy.
Watanabe-Kusunoki K; Nakazawa D; Yamamoto J; Matsuoka N; Kaneshima N; Nakagaki T; Yamamoto R; Maoka T; Iwasaki S; Tsuji T; Fukasawa Y; Nishimoto N; Nishio S; Atsumi T
Medicine (Baltimore); 2021 Dec; 100(50):e27778. PubMed ID: 34918629
[TBL] [Abstract][Full Text] [Related]
10. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
Kawamura T
Contrib Nephrol; 2007; 157():37-43. PubMed ID: 17495435
[TBL] [Abstract][Full Text] [Related]
11. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
Ogura S; Moriyama T; Miyabe Y; Karasawa K; Nitta K
Clin Exp Nephrol; 2021 Oct; 25(10):1103-1110. PubMed ID: 34101029
[TBL] [Abstract][Full Text] [Related]
14. Utility of remission criteria for the renal prognosis of IgA nephropathy.
Matsuzaki K; Suzuki H; Kawamura T; Tomino Y; Suzuki Y
Clin Exp Nephrol; 2021 Sep; 25(9):988-995. PubMed ID: 33974158
[TBL] [Abstract][Full Text] [Related]
15. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
Ohya M; Otani H; Minami Y; Yamanaka S; Mima T; Negi S; Yukawa S; Shigematsu T
Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
[TBL] [Abstract][Full Text] [Related]
16. Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy.
Hirano K; Matsuzaki K; Yasuda T; Nishikawa M; Yasuda Y; Koike K; Maruyama S; Yokoo T; Matsuo S; Kawamura T; Suzuki Y
JAMA Netw Open; 2019 May; 2(5):e194772. PubMed ID: 31150076
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study.
Li Y; Wan Q; Lan Z; Xia M; Liu H; Chen G; He L; Wang C; Liu H
PeerJ; 2022; 10():e14481. PubMed ID: 36523468
[TBL] [Abstract][Full Text] [Related]
19. Retrospective comparison of the efficacy of tonsillectomy with and without steroid-pulse therapy in IgA nephropathy patients.
Nakagawa N; Kabara M; Matsuki M; Chinda J; Fujino T; Hirayama T; Takahara M; Harabuchi Y; Kikuchi K; Hasebe N
Intern Med; 2012; 51(11):1323-8. PubMed ID: 22687836
[TBL] [Abstract][Full Text] [Related]
20. Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study.
Miyamoto T; Nishino T; Nakata T; Sato Y; Komatsu H; Uramatsu T; Ishimatsu N; Ishida K; Serino R; Otsuji Y; Miyazaki M; Tomo T; Tamura M; Fujimoto S
Clin Exp Nephrol; 2016 Feb; 20(1):50-7. PubMed ID: 26055039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
